Modified virus teams up with chemo in fight against tough head and neck cancers
NCT ID NCT07398664
Summary
This study is testing a two-part treatment for head and neck cancer that has returned or spread after standard treatments. Doctors will inject a modified virus (H101) designed to attack cancer cells directly into the tumor, combined with a targeted chemotherapy procedure (TACE) that delivers drugs and blocks the tumor's blood supply. The goal is to see if this combination can shrink tumors and control the disease with manageable side effects for up to 20 patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.